Effectiveness and Safety of a Multicenter Extension and Retreatment Trial of Gel-200 in Patients with Knee Osteoarthritis. - Wikidata - awgldk - TriplyDB

Effectiveness and Safety of a Multicenter Extension and Retreatment Trial of Gel-200 in Patients with Knee Osteoarthritis.

Effectiveness and Safety of a Multicenter Extension and Retreatment Trial of Gel-200 in Patients with Knee Osteoarthritis.

http://www.wikidata.org/entity/Q34978098

about

Viscosupplementation for osteoarthritis: a primer for primary care physicians Evidence for safety of retreatment with a single intra-articular injection of Gel-200 for treatment of osteoarthritis of the knee from the double-blind pivotal and open-label retreatment clinical trials.A Pooled Analysis of Two Multicenter, Randomized Controlled Trials of a Single Intra-articular Injection of Gel-200 for Treatment of Osteoarthritis of the Knee.

P2860

Q35153951-0B3CAC7D-FEA8-4F20-BFA9-ACF28B5C5C2F Q36036993-6814CAF4-52C3-49A4-B456-8EDB8990A9E2 Q55032393-70C9411C-468A-469D-9A9F-FA68879D0DF9

P2860

Effectiveness and Safety of a Multicenter Extension and Retreatment Trial of Gel-200 in Patients with Knee Osteoarthritis.

http://www.wikidata.org/entity/Q34978098

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Effectiveness and Safety of a ...... ents with Knee Osteoarthritis.

@ast

Effectiveness and Safety of a ...... ents with Knee Osteoarthritis.

@en

Effectiveness and Safety of a ...... ents with Knee Osteoarthritis.

@nl

type

label

Effectiveness and Safety of a ...... ents with Knee Osteoarthritis.

@ast

Effectiveness and Safety of a ...... ents with Knee Osteoarthritis.

@en

Effectiveness and Safety of a ...... ents with Knee Osteoarthritis.

@nl

prefLabel

Effectiveness and Safety of a ...... ents with Knee Osteoarthritis.

@ast

Effectiveness and Safety of a ...... ents with Knee Osteoarthritis.

@en

Effectiveness and Safety of a ...... ents with Knee Osteoarthritis.

@nl

P1433

Q34978098-5D7530C7-A56A-4F08-B210-7E4EAAE4130A

P1476

Q34978098-7DB58DDE-F4E1-4FB7-8785-384E0DD647CD

P2093

Q34978098-01A4C230-1B98-42B1-A114-B6793AE131FE

Q34978098-75B92EE7-012E-4441-B3F7-2FC7FC4A7961

Q34978098-7B7B34C8-A385-42EC-95E2-8314DB29A938

Q34978098-7D2FDE92-A50C-4AE0-8855-5ECA8E6CFB12

Q34978098-99F9CFF7-7B8F-4E8C-8DC5-224DF6A95CF7

P2860

Q34978098-0209483A-9DDA-47B3-BF66-CE9B1F863AE5

Q34978098-1A395CE0-D09E-441F-91E5-19285331486E

Q34978098-3AD1E1F5-0D14-45AB-824A-175B15275B93

Q34978098-4807FABB-534E-4164-B979-52C166403A64

Q34978098-4F379054-D917-47F2-BC53-7ED2FBF7516F

Q34978098-61A571ED-4733-4D6B-8FF7-8865CF7BE5D4

Q34978098-9E78C9B2-98E7-4AB1-AE2C-1F14EF149338

Q34978098-9FF50ADC-CCD2-4F76-A457-ACD4AD335F27

Q34978098-A9589E04-9C1C-45A9-BBC7-904F9DE83100

Q34978098-AC658AF9-1FC7-4AAB-8B28-EBAE17CB8A82

P304

Q34978098-05721691-4A6C-4055-9F3A-FCA63A35F161

P31

Q34978098-C94837F8-4A33-4168-A59E-E9A733A13751

P356

Q34978098-90D2EACC-C8FA-4759-B535-647F2E7AA2CE

P433

Q34978098-E11059F2-5C61-4104-B139-C14307C49D8D

P478

Q34978098-80B96F05-5F6E-4233-81F0-C440CF65DFCE

P577

Q34978098-2F8DC0AE-A9CF-4E28-A1FB-115CFBBB6930

P5875

Q34978098-143C271B-0E94-452B-995D-76E80B512DA7

P698

Q34978098-329F668C-F3EF-4BB9-99F8-A52B1F11B4AB

P921

Q34978098-4EECE344-6C3E-446F-AD93-FC16114E4B3B

Q34978098-D9D7AA4F-8CBA-4596-AC16-66442A7CD6D3

P932

Q34978098-C7E206F1-EC74-4CF8-9B16-50FC717F110B

P356

1947603512451024

P1433

P1476

Effectiveness and Safety of a ...... ents with Knee Osteoarthritis.

@en

P2093

H Hosokawa

http://www.w3.org/2001/XMLSchema#string

H S B Baraf

http://www.w3.org/2001/XMLSchema#string

P T Lavin

http://www.w3.org/2001/XMLSchema#string

S Lim

http://www.w3.org/2001/XMLSchema#string

V Strand

http://www.w3.org/2001/XMLSchema#string

P2860

Viscosupplementation for the treatment of osteoarthritis of the knee

EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)

OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines.

Response criteria for clinical trials on osteoarthritis of the knee and hip: a report of the Osteoarthritis Research Society International Standing Committee for Clinical Trials response criteria initiative.

Outcome variables for osteoarthritis clinical trials: The OMERACT-OARSI set of responder criteria.

Pseudoseptic reactions to hylan viscosupplementation: diagnosis and treatment.

The impact of osteoarthritis: implications for research.

Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial.

A double-blind, randomized, saline-controlled study of the efficacy and safety of EUFLEXXA for treatment of painful osteoarthritis of the knee, with an open-label safety extension (the FLEXX trial).

Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trial.

P304

297-304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1947603512451024

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258127822

http://www.w3.org/2001/XMLSchema#string

P698

26069640

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

P932

4297150

http://www.w3.org/2001/XMLSchema#string